CNS & Neurological Disorders - Drug Targets
Title:Commentary: Olfactory Dysfunction in Parkinson’s Disease
Volume: 12 Issue: 8
Author(s): Jiang Li, Ying Cui, Ti-Fei Yuan and Oscar Arias-Carrion
Affiliation:
Export Options
About this article
Cite this article as:
Li Jiang, Cui Ying, Yuan Ti-Fei and Arias-Carrion Oscar, Commentary: Olfactory Dysfunction in Parkinson’s Disease, CNS & Neurological Disorders - Drug Targets 2013; 12 (8) . https://dx.doi.org/10.2174/1871527312999131230144317
DOI https://dx.doi.org/10.2174/1871527312999131230144317 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
31
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Understanding the Role of Histone Deacetylase and their Inhibitors in
Neurodegenerative Disorders: Current Targets and Future Perspective
Current Neuropharmacology Neuropharmacological Mechanisms Underlying the Neuroprotective Effects of Methylphenidate
Current Neuropharmacology Exploring the Abnormal Signal Transduction Mediated Internet Addiction and Gaming Disorders
Current Signal Transduction Therapy Conference Proceedings: Second International Conference on Novel Psychoactive Substances (NPS) Swansea, UK; September 12-13th, 2013
Current Drug Abuse Reviews Serotonin 5-HT6 Receptor Antagonists for the Treatment of Alzheimers Disease
Current Topics in Medicinal Chemistry Microporation Techniques for Enhanced Delivery of Therapeutic Agents
Recent Patents on Drug Delivery & Formulation HIV-1 Tat Disrupts CX3CL1-CX3CR1 Axis in Microglia via the NF-κBYY1 Pathway
Current HIV Research Targeting Striatal Metabotropic Glutamate Receptor Type 5 in Parkinson’s Disease: Bridging Molecular Studies and Clinical Trials
CNS & Neurological Disorders - Drug Targets Amyloidogenesis of Natively Unfolded Proteins
Current Alzheimer Research Chemotherapy Delivery Strategies to the Central Nervous System: neither Optional nor Superfluous
Current Cancer Drug Targets Recent Kinase and Kinase Inhibitor X-ray Structures: Mechanisms of Inhibition and Selectivity Insights
Current Medicinal Chemistry Tyrosine Kinases as Therapeutic Targets in BCR-ABL Negative Chronic Myeloproliferative Disorders
Current Drug Targets Skin Regeneration: The Possibilities
Recent Patents on Regenerative Medicine Functional Domains of Aquaporin-1: Keys to Physiology, and Targets for Drug Discovery
Current Pharmaceutical Design Critical Issues in Nanofluids Preparation, Characterization and Thermal Conductivity
Current Nanoscience Aggregation, Sorting and Transport of Chromogranins in the Regulated Secretory Pathway
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents MicroRNAs: Newcomers into the ALS Picture
CNS & Neurological Disorders - Drug Targets Properties and Therapeutic Potential of Transient Receptor Potential Channels with Putative Roles in Adversity: Focus on TRPC5, TRPM2 and TRPA1
Current Drug Targets The Contribution of Oxazolidinone Frame to The Biological Activity of Pharmaceutical Drugs and Natural Products
Mini-Reviews in Medicinal Chemistry Signal-Dependent Noise Induces Muscle Co-Contraction to Achieve Required Movement Accuracy: A Simulation Study with an Optimal Control
Current Bioinformatics